Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT or RBT vs Vancomycin for Recurrent CDI
NCT02774382Phase 3Unknown
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- May 2017
- Primary completion
- Dec 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of allogeneic fecal microbiota and rectal bacteriotherapy in Clostridium difficile infection (CDI), sponsored by Copenhagen University Hospital - Hvidovre. Status: unknown.
02
Drugs
allogeneic fecal microbiotarectal bacteriotherapy
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT02774382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02774382.